AstraZeneca's hopes for baxdrostat are high, as in early 2023 it acquired the drug by purchasing its developer -- biotech ...
A recent Lancet study reveals that Chronic Kidney Disease (CKD) has doubled globally since 1990, now affecting nearly 800 ...
Black adults living in communities with few grocery stores who participated in a grocery support program providing ...
(Alliance News) - AstraZeneca PLC on Sunday announced results from the phase 3 trial of its Baxdrostat treatment which showed a statistically significant reduction in the systolic blood pressure of ...
High blood pressure, also called hypertension, is a condition in which the blood force against the body’s blood vessels is consistently too high. Think of it like too much pressure in a garden hose.
Positive full results from the Bax24 Phase III trial showed baxdrostat demonstrated a statistically significant and highly clinically meaningful reduction in ambulatory 24-hour average systolic blood ...
One major cause of high systolic blood pressure is eating too much salt. Salt contains sodium, and when there is too much ...
A record-breaking 4,432 scientific abstracts accepted at the American Heart Association’s meeting here adorned posters, ...
Hypertension can also raise the risk of other health problems, including kidney disease and dementia. The link between blood ...
AstraZeneca's aldosterone synthase inhibitor baxdrostat reduced blood pressure by 14 mmHg over 12 weeks, the pharma has said ...
Historically, I’ve been a bit weary of heated workouts. The increased temps make you extra sweaty (obviously), and they’re also just harder on your body. Much like the thermostat, every system that ...
Distinct demographic, systemic sclerosis-specific, and cardiac factors are linked to a higher risk for left ventricular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback